The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns naming John Callinan .

Filed returns
17
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2015: 1 filed returns Sep–Dec 2018: 1 filed returns Jan–Apr 2019: 1 filed returns Jan–Apr 2021: 4 filed returns Sep–Dec 2022: 2 filed returns Sep–Dec 2024: 3 filed returns Jan–Apr 2025: 5 filed returns 2019 2021 2025
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2025 Irish Pharmaceutical Healthcare Association Health (i) Proposed revision of EU General Pharmaceutical Legislation and Irish Government position on intellectual Property rights; (ii) Industry position on a National Life Sciences Strategy; (iii) EU and Irish… (Legislation) 4 On lobbying.ie
Jan–Apr 2025 Irish Pharmaceutical Healthcare Association Health (i) Proposed revision of EU General Pharmaceutical Legislation and Irish Government position on intellectual Property rights; (ii) Industry position on a National Life Sciences Strategy; (iii) EU and Irish… (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2025 Irish Pharmaceutical Healthcare Association Health EU Competitiveness, EU General Pharmaceutical Legislation (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2025 Irish Pharmaceutical Healthcare Association Health Interdepartmental Policy Co-Ordination. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2025 Irish Pharmaceutical Healthcare Association Health Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) 12 On lobbying.ie
Sep–Dec 2024 Irish Pharmaceutical Healthcare Association Health EU Commission proposed revision of the EU General Pharmaceutical Legislation and related matters, with particular attention to intellectual property rights provisions, competitiveness and regulatory affairs. (Legislation) 8 On lobbying.ie
Sep–Dec 2024 Irish Pharmaceutical Healthcare Association Health Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) 13 On lobbying.ie
Sep–Dec 2024 Irish Pharmaceutical Healthcare Association Health European Commission Urban Waste Water Treatment Directive (UWWTD), with particular attention to the polluter payers principal and proportional responsibility. (Legislation) 8 On lobbying.ie
Sep–Dec 2022 Bon Secours Health System CLG Health Raised the possibility of including frontline Private Hospital healthcare staff in the Pandemic Bonus Payment scheme (Public policy or programme) 6 On lobbying.ie
Sep–Dec 2022 Private Hospitals Association Health Covid Bonus payment for Healthcare staff in private hospitals (Matters involving public funds) 5 On lobbying.ie
Jan–Apr 2021 Paul Allen & Associates Public Relations Health Mandatory Hotel Quarantine (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2021 Paul Allen & Associates Public Relations Health Introduction of mandatory hotel quarantine (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2021 Alcohol Action Ireland Health Public Health Alcohol Act 2018 (Legislation) 33 On lobbying.ie
Jan–Apr 2021 Chambers Ireland Health To highlight to Taoiseach and other Ministers a new survey launched by the International Chamber of Commerce about the economic implications of developing countries not receiving COVID 19 vaccines (Public policy or programme) 8 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health To highlight importance of continuity of supply of medicines in Europe post Brexit (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Inclusion of medicine regulation in Brexit withdrawal agreement (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2015 Irish Medical Organisation Health IMO 2016 Budget Submission Recommendations for Government (Matters involving public funds) 88 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 17 100.0%